The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.

System offers real-time diabetic ketoacidosis warnings

Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes